Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monitor: Int Med J Experimental Clin Res 16(2):BR61–67

CAS  Google Scholar 

Ahn JH, Kim M, Park S, Jang W, Park J, Oh E, Cho JW, Kim JS, Youn J (2020) Prolonged-release melatonin in Parkinson’s disease patients with a poor sleep quality: a randomized trial. Parkinsonism Relat Disord 75:50–54

Article  PubMed  Google Scholar 

Al-Buhadily AK, Al-Uqabi RU, Al-Gareeb AI (2023) Evaluation of Protective Effect of Metformin in rats with experimental osteoarthritis. Mustansiriya Med J 22(1):50–53

Article  Google Scholar 

Al-Kuraishi AH, Khalil HI, Hasan HH, Al-Kuraishy HM (2021) Are alterations in melatonin and inflammatory cytokine serum levels linked with recurrent abortion in pregnant women with acute toxoplasmosis: the interacted nexus. Parity 1:0–94

Google Scholar 

Al-Kuraishi AH, Khalil HI, Hassan HH, Al-kuraishy HM (2023) Placental dysfunction and acute toxoplasmosis: the role of melatonin in relation to inflammatory cytokines Interleukin-10 and Interleukin-12. J Microscopy Ultrastructure 11(2):87–91

Article  Google Scholar 

Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Albuhadily AK (2023) The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways. Ageing Research Reviews. a 14:102075

Al-kuraishy HM, Al‐Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GE (2023) SARS‐COV‐2 infection and Parkinson’s disease: possible links and perspectives. J Neurosci Res 101(6):952–975 c

Article  PubMed  CAS  Google Scholar 

Al-Kuraishy HM, Al-Gareeb AI, Elewa YH, Zahran MH, Alexiou A, Papadakis M, Batiha GE (2023b) Parkinson’s disease risk and hyperhomocysteinemia: the possible link. Cellular and Molecular Neurobiology. b 19:1–7

Al-Kuraishy HM, Al-Gareeb AI, Selim HM, Alexiou A, Papadakis M, Negm WA, Batiha GE (2023c) Does vitamin D protect or treat Parkinson’s disease? A narrative review. Naunyn-Schmiedeberg’s Archives of Pharmacology. d 9:1–8

Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Saad HM, Batiha GE, Klionsky DJ The beneficial role of autophagy in multiple sclerosis: yes or no? Autophagy 2023 i 27:1–6

Alghamdi B (2018) The neuroprotective role of melatonin in neurological disorders. J Neurosci Res 96(7):1136–1149

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Saad HM, Batiha GE (2023) The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads. Molecular Neurobiology. a 28:1–2

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Saad HM, Batiha GE (2023b) Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator. Mol Med 29(1):142

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ali NH, Alhamdan NA, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE (2023c) Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes. Naunyn Schmiedebergs Arch Pharmacol b11:1–1

Google Scholar 

Alnaaim SA, Al-Kuraishy HM, Alexiou A, Papadakis M, Saad HM, Batiha GE Role of brain liver X receptor in Parkinson’s disease: hidden treasure and emerging opportunities. Mol Neurobiol 2023 Aug 22:1–7

Alrouji M, Al-Kuraishy HM, Al-Mahammadawy AK, Al-Gareeb AI, Saad HM, Batiha GE (2023) The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim. Neurol Sci a10:1–4

Google Scholar 

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Ashour NA, Jabir MS, Negm WA, Batiha GE (2023b) Metformin role in Parkinson’s disease: a double-sword effect. Molecular and Cellular Biochemistry. d 2:1–7

Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson’s disease. Brain 132(Pt 5):1128–1145. https://doi.org/10.1093/brain/awp068

Article  PubMed  Google Scholar 

Arioz BI, Tarakcioglu E, Olcum M, Genc S (2021) The role of melatonin on NLRP3 inflammasome activation in diseases. Antioxidants 10(7):1020

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asadpoordezaki Z, Coogan AN, Henley BM (2023) Chronobiology of Parkinson’s disease: past, present and future. Eur J Neurosci 57(1):178–200

Article  PubMed  CAS  Google Scholar 

Biran V, Decobert F, Bednarek N, Boizeau P, Benoist J-F, Claustrat B, Barré J, Colella M, Frérot A, Garnotel R (2019) Melatonin levels in preterm and term infants and their mothers. Int J Mol Sci 20(9):2077

Article  PubMed  PubMed Central  CAS  Google Scholar 

Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson’s disease. Lancet Neurol 19(2):170–178

Article  PubMed  CAS  Google Scholar 

Bordet R, Devos D, Brique S, Touitou Y, Guieu J, Libersa C, Destee A (2003) Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol 26(2):65–72

Article  PubMed  CAS  Google Scholar 

Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP (2020) Melatonin receptor ligands: a pharmaco‐chemical perspective. J Pineal Res 69(3):e12672

Article  PubMed  CAS  Google Scholar 

Brancaccio M, Edwards MD, Patton AP, Smyllie NJ, Chesham JE, Maywood ES, Hastings MH (2019) Cell-autonomous clock of astrocytes drives circadian behavior in mammals. Science 363(6423):187–192

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bubenik G, Konturek S (2011) Melatonin and aging: prospects for human treatment. J Physiol Pharmacol 62(1):13

PubMed  CAS  Google Scholar 

Buijink MR, Michel S (2021) A multi-level assessment of the bidirectional relationship between aging and the circadian clock. J Neurochem 157(1):73–94

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cerri S, Mus L, Blandini F (2019) Parkinson’s disease in women and men: what’s the difference? J Parkinson’s Disease 9(3):501–515

Article  Google Scholar 

Choudhury ME, Miyanishi K, Takeda H, Tanaka J (2021) Microglia and the aging brain: are geriatric Microglia Linked to Poor Sleep Quality? Int J Mol Sci 22(15):7824

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cochrane A, Robertson IH, Coogan AN (2012) Association between circadian rhythms, sleep and cognitive impairment in healthy older adults: an actigraphic study. J Neural Transm 119:1233–1239

Article  PubMed  Google Scholar 

De Pablo-Fernández E, Courtney R, Warner TT, Holton JL (2018) A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol 75(8):1008–1012

Article  PubMed  PubMed Central  Google Scholar 

Dibner C, Schibler U, Albrecht U (2010) The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 72:517–549

Article  PubMed  CAS  Google Scholar 

Fifel K, Cooper HM (2014) Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson’s disease. Neurobiol Dis 71:359–369

Article  PubMed  CAS  Google Scholar 

Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A (2017) Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther 23(1):5–22

Article  PubMed  Google Scholar 

Griffin P, Dimitry JM, Sheehan PW, Lananna BV, Guo C, Robinette ML, Hayes ME, Cedeño MR, Nadarajah CJ, Ezerskiy LA (2019) Circadian clock protein Rev-erbα regulates neuroinflammation. Proc Natl Acad Sci 116(11):5102–5107

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hastings MH, Maywood ES, Brancaccio M (2018) Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci 19(8):453–469

Article  PubMed  CAS  Google Scholar 

Hirata F, Hayaishi O, Tokuyama T, Senoh S (1974) In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 249(4):1311–1313

Article  PubMed  CAS  Google Scholar 

Ibrahim HA, Hussein AM, Gabr M, El-Saeed RA, Ammar OA, Mosa AA, Abdel-Aziz AA (2023) Effect of melatonin on alpha synuclein and autophagy in dopaminergic neuronal differentiation of adipose mesenchymal stem cells. Rep Biochem Mol Biology 12(1):13

CAS  Google Scholar 

Janda E, Isidoro C, Carresi C, Mollace V (2012) Defective autophagy in Parkinson’s disease: role of oxidative stress. Mol Neurobiol 46:639–661

Article  PubMed  CAS  Google Scholar 

Jiang W, Wu H, Yu X, Wang Y, Gu W, Wei W, Li B, Jiang X, Wang Y, Hou W (2021) Third-hand smoke exposure is associated with abnormal serum melatonin level via hypomethylation of CYP1A2 promoter: evidence from human and animal studies. Environ Pollut 277:116669